salesforce.com (NYSE:CRM) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Share on StockTwits

salesforce.com (NYSE:CRM) announced its quarterly earnings results on Tuesday. The CRM provider reported $0.75 EPS for the quarter, beating analysts’ consensus estimates of $0.66 by $0.09, Bloomberg Earnings reports. The company had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.45 billion. salesforce.com had a return on equity of 7.26% and a net margin of 6.45%. salesforce.com’s revenue was up 33.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.61 EPS.

Shares of CRM traded up $0.57 during mid-day trading on Tuesday, hitting $161.57. 6,531,594 shares of the company’s stock were exchanged, compared to its average volume of 5,696,642. The company has a market cap of $142.85 billion, a PE ratio of 111.43, a P/E/G ratio of 7.00 and a beta of 1.24. salesforce.com has a 52 week low of $120.16 and a 52 week high of $167.56. The company has a 50-day simple moving average of $157.11 and a 200 day simple moving average of $153.41. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.97 and a quick ratio of 0.97.

Several research analysts recently weighed in on the stock. Mizuho reissued a “buy” rating and set a $195.00 price objective on shares of salesforce.com in a research note on Thursday, November 21st. OTR Global raised shares of salesforce.com to a “positive” rating in a research note on Thursday, August 15th. BMO Capital Markets increased their target price on shares of salesforce.com from $185.00 to $188.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Jefferies Financial Group reiterated a “buy” rating and issued a $195.00 target price (up from $171.00) on shares of salesforce.com in a report on Sunday, November 17th. Finally, Monness Crespi & Hardt lifted their price target on shares of salesforce.com from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Friday, August 23rd. Three analysts have rated the stock with a hold rating, thirty-seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $187.31.

In related news, insider Srinivas Tallapragada sold 1,608 shares of salesforce.com stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $162.57, for a total value of $261,412.56. Following the sale, the insider now owns 34,719 shares of the company’s stock, valued at $5,644,267.83. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, General Counsel Amy E. Weaver sold 5,259 shares of salesforce.com stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $151.65, for a total value of $797,527.35. Following the completion of the sale, the general counsel now directly owns 30,005 shares in the company, valued at approximately $4,550,258.25. The disclosure for this sale can be found here. Insiders sold 206,671 shares of company stock worth $31,877,449 over the last quarter. 5.50% of the stock is owned by corporate insiders.

About salesforce.com

salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, and gain insights through analytics and relationship intelligence, as well as deliver quotes, contracts, and invoices.

Recommended Story: FAANG Stocks

Earnings History for salesforce.com (NYSE:CRM)

Receive News & Ratings for salesforce.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for salesforce.com and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.